Targeting the Insulin-like Growth Factor 1 (IGF1R) and Insulin (IR) Receptor with a Dual IGF1R/IR Inhibitor, OSI-906, to Potentiate mTOR Inhibitor Effects in Exeperimental Models of Hepatocellular Carcinoma (HOC)

被引：0

作者：

Pivonello, Claudia ^{[1
]}

Negri, Mariarosaria ^{[1
]}

De Martino, Maria Cristina ^{[1
]}

Napolitano, Maria ^{[2
]}

de Angelis, Cristina ^{[1
]}

Izzo, Francesco ^{[2
]}

Colao, Annamaria ^{[1
]}

Hofland, Leo J. ^{[3
]}

Pivonello, Rosario ^{[1
]}

机构：

[1] Univ Naples Federico II, Naples, Italy

[2] Natl Canc Inst G Pascale Fdn, Naples, Italy

[3] Erasmus MC, Rotterdam, Netherlands

来源：

ENDOCRINE REVIEWS | 2014年 / 35卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

SAT-0320

引用

页数：3

共 50 条

[1] Generation of in vivo tumor models driven by Insulin-Like Growth Factor 1 Receptor IGF1R and their use in the development of OSI-906, a selective IGF1R inhibitor
Lerner, Lorena
Liu, Qing
Yang, John
Tao, Nianjun
Krieger, Brian
Zarycki, Jodi
Huang, Lu
Growney, Joseph
Buck, Elizabeth
Wang, Ruojie
Rosenfeld-Franklin, Maryland
Kannnan, Karuppiah
Kan, Julie
Pachter, Jonathan
Chiu, Maria Isabel
Epstein, David
Robinson, Murray
CANCER RESEARCH, 2009, 69
[2] Generation of in vitro and in vivo tumor models driven by insulin-like growth factor receptor (IGF1R) and their use in the development of OSI-906, a selective IGF1R inhibitor
Liu, Qing
Lorena, Lerner
Tao, Nianjun
Huang, Lu
Yang, John
Krieger, Brian
Buck, Elizabeth
Wang, Ruojie
Kannan, Karuppiah
Chiu, M. Isabel
Robinson, Murray O.
MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
[3] Inhibition of IGF1R by IGF1R/IR inhibitor OSI906 as a targeted therapy for glioblastoma: in vitro & in vivo studies
Celia Fernandez, Maria
Martin, Ayelen
Clement, Florencia
Venara, Marcela
Fernanda Castro, Julia
Garcia Lombardi, Mercedes
Bergada, Ignacio
Pennisi, Patricia
HORMONE RESEARCH IN PAEDIATRICS, 2019, 91 : 62 - 63
[4] OSI-906: A DUAL IGF-1R/IR INHIBITOR FOR THE TREATMENT OF CANCER
Buck, E.
Gokhale, P.
Lerner, L.
Wild, R.
Pachter, J.
Epstein, D.
Miglarese, M.
ANNALS OF ONCOLOGY, 2010, 21 : 9 - 10
[5] Combination strategies for OSI-906, a small molecule inhibitor of the insulin-like growth factor receptor, IGF-1R
Buck, E.
Eyzaguirre, A.
Rosenfeld-Franklin, M.
Ji, Q.
Mulvihill, M.
Wild, R.
Epstein, D.
Iwata, K.
Haley, J.
Pachter, J.
Miglarese, M.
ANNALS OF ONCOLOGY, 2008, 19 : 43 - 43
[6] Inhibition Of IGF1R by IGF-1R/IR Inhibitor OSI906 as a Targeted Therapy for Glioblastoma: In Vitro & in Vivo Studies
Fernandez, M. C.
Martin, A.
Clement, F.
Venara, M. C.
Garcia Lombardi, M.
Bergada, I
Gutierrez, M.
Pennisi, P. A.
HORMONE RESEARCH IN PAEDIATRICS, 2019, 92 : 12 - 12
[7] In vivo evaluation of OSI-906, a novel small molecule kinase inhibitor of the insulin-like growth factor-1 receptor (IGF-IR)
Rosenfeld-Franklin, Maryland
Cooke, Andy
Pirritt, Caroline
Landfair, Darla
Silva, Stacia
Turton, Roy
Feng, Lixin
Mulvihill, Mark J.
Buck, Elizabeth
Pachter, Jonathan A.
Ji, Qun-Sheng
Wild, Robert
MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3509S - 3509S
[8] Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapy
Tognon, Cristina E.
Sorensen, Poul H. B.
EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 (01) : 33 - 48
[9] Targeting insulin-like growth factor-1 receptor (IGF1R) for brain delivery of biologics
Alata, Wael
Yogi, Alvaro
Brunette, Eric
Delaney, Christie E.
van Faassen, Henk
Hussack, Greg
Iqbal, Umar
Kemmerich, Kristin
Haqqani, Arsalan S.
Moreno, Maria J.
Stanimirovic, Danica B.
FASEB JOURNAL, 2022, 36 (03):
[10] Simultaneous Loss of Podocyte Insulin Receptor (IR) and Insulin-Like Growth Factor 1 Receptor (IGF1R) Is Detrimental and Associated with Spliceosome Dysfunction
Hurcombe, Jenny
Dayalan, Lusyan
Barrington, Fern
Ni, Lan
Brinkkoetter, Paul T.
Holzenberger, Martin
Welsh, Gavin I.
Coward, Richard
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 526 - 526

← 1 2 3 4 5 →